Melioidosis is an important cause of community-acquired infection in Southeast Asia and northern Australia. Studies from endemic countries have demonstrated differences in the epidemiology and clinical features among children diagnosed with melioidosis. This suggests that local data are needed to determine the risk factors and outcome in specific areas.
Biological methods are promising treatment methods to remove pollutants from wastewater. Recently, microalgae have been proved to be of strong application potential in wastewater treatment. In this study, a microalga - antibiotic treatment system was built to evaluate the treatment capacity of microalgae in antibiotic wastewater. In the group with Chlorella pyrenoidosa, the removal rate of cefradine was 41.47 ± 0.62% after 24 h of treatment, which was 3.4 times higher than that without microalgae (12.37 ± 2.30%). Algal decomposition was the main removal mechanism. Meanwhile, the effect of multiple microalgae species on antibiotic treatment was studied. The removal rates of cefradine by C. pyrenoidosa cultivated in the filtered fluid of Microcystis aeruginosa were 75.48 ± 0.29%, which was significantly higher than those by C. pyrenoidosa only. Those indicated that multiple microalgae species strategy was a potential enhancement strategy for algae-based antibiotic treatment. Finally, amoxicillin and norfloxacin were used to study the treatment potential of this technology for more different kinds antibiotics and the integration of microalgae with activated sludge was also investigated. Amoxicillin can be quickly removed by microalgae, but the removal effect of norfloxacin by microalgae is poor. The refractory antibiotic norfloxacin can be treated by co-culturing microalgae and activated sludge. Those showed the good expansibility of microalgae-based technology. The findings indicated that with microalgae-based antibiotic removal method has good application potential, and combined with other technologies, it can effectively remove the refractory antibiotics.
Antibiotics, as antimicrobial drugs, have been widely applied as human and veterinary medicines. Recently, many antibiotics have been detected in the environments due to their mass production, widespread use, but a lack of adequate treatment processes. The environmental occurrence of antibiotics has received worldwide attention due to their potential harm to the ecosystem and human health. Research status of antibiotics in the environment field is presented by bibliometrics. Herein, we provided a comprehensive overview on the following important issues: (1) occurrence of antibiotics in different environmental compartments, such as wastewater, surface water, and soil; (2) toxicity of antibiotics toward non-target organisms, including aquatic and terrestrial organisms; (3) current treatment technologies for the degradation and removal of antibiotics, including adsorption, hydrolysis, photodegradation and oxidation, and biodegradation. It was found that macrolides, fluoroquinolones, tetracyclines, and sulfonamides were most frequently detected in the environment. Compared to surface and groundwaters, wastewater contained a high concentration of antibiotic residues. Both antibiotics and their metabolites exhibited toxicity to non-target organisms, especially aquatic organisms (e.g., algae and fish). Fluoroquinolones, tetracyclines, and sulfonamides can be removed through abiotic process, such as adsorption, photodegradation, and oxidation. Fluoroquinolones and sulfonamides can directly undergo biodegradation. Further studies on the chronic effects of antibiotics at environmentally relevant concentrations on the ecosystem were urgently needed to fully understand the hazards of antibiotics and help the government to establish the permissible limits. Biodegradation is a promising technology; it has numerous advantages such as cost-effectiveness and environmental friendliness.